logo

For the Inventor, By the Inventor

Hyderabad Telangana, India

Natco Pharma Limited


USPTO Granted Patents = 49



Forward Citations = 48

Loading Chart...
Loading Chart...

88 inventors (with patents filed for the assignee):

goldMedal Venkaiah Chowdary Nannapaneni (26 out of 26 patents)

silverMedal Nannapaneni Venkaiah Chowdary (22 out of 22 patents)

bronzeMedal Bhujanga Rao Adibhatla Kali Satya (16 out of 16 patents)

4.  Durga Prasad Konakanchi (13 out of 14 patents)

5.  Kali Satya Bhujanga Rao Adibhatla (11 out of 11 patents)

6.  Pulla Reddy Muddasani (10 out of 10 patents)

7.  Amala Kompella (10 out of 10 patents)

8.  Sreenivas Rachakonda (9 out of 9 patents)

9.  Ramanadham Jyothi Prasad (8 out of 8 patents)

10.  Buchappa Gongalla (6 out of 6 patents)

11.  Venugopala Krishna Gampa (5 out of 5 patents)

12.  Srinivasa Krishna Murthy Konduri (4 out of 4 patents)

13.  Bollepalli Nageshwara Rao (4 out of 4 patents)

14.  Janaki Rama Rao Ravi (3 out of 3 patents)

15.  Uma Naresh Babu Kotra (3 out of 3 patents)


Core Competencies:
Sugammadex Sodium
Trifluridine
Ibrutinib
Cabozantinib
Ribociclib Succinate
Pomalidomide
Idelalisib
Dasatinib Polymorph
Ceritinib
Lenalidomide
Erlotinib Hydrochloride
Nilotinib

49 patents:

1. 12522611 - Process for the preparation of high pure Eribulin and its Mesylate salt (2026-01-13),
2. 11845811 - Process for the preparation of Sugammadex sodium and its novel polymorphic form (2023-12-19),
3. 11730753 - Stable pharmaceutical compositions comprising trifluridine and tipiracil hydrochloride (2023-08-22),
4. 11576917 - Pharmaceutical compositions comprising Ibrutinib (2023-02-14),
5. 11498902 - Process for the preparation of Cabozantinib and its pharmaceutically acceptable salts thereof (2022-11-15),
6. 11465988 - Process for the preparation of Tipiracil hydrochloride and intermediates thereof (2022-10-11),
7. 11452722 - Stable pharmaceutical compositions comprising lenalidomide (2022-09-27),
8. 11414421 - Process for the preparation of ribociclib succinate and its novel crystalline forms thereof (2022-08-16),
9. 11111228 - Process for the preparation of pomalidomide and its purification (2021-09-07),
10. 11091470 - Process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochloride (2021-08-17),
11. 11008296 - Intermediates for the preparation of eribulin thereof (2021-05-18),
12. 10966971 - Pharmaceutical compositions of pomalidomide (2021-04-06),
13. 10870650 - Process for the preparation of amorphous idelalisib (2020-12-22),
14. 10800771 - Process for the preparation of dasatinib polymorph (2020-10-13),
15. 10626117 - Process for the preparation of Ibrutinib (2020-04-21),
Natco Pharma Limited is a publicly listed pharmaceutical company headquartered in India. Established in 1981, Natco specializes in the development, manufacturing, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company primarily focuses on oncology, hepatitis C, and other therapeutic segments. With a mission to provide affordable and accessible healthcare solutions, Natco has a strong global presence and exports its products to various countries. Their commitment to quality, innovation, and social responsibility have made them a trusted name in the pharmaceutical industry.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

...
49 Patents

#4 in Hyderabad Telangana

#36 in India

#13,907 in the World

...
Hyderabad Telangana, India

Natco Pharma Limited

Forward Citations = 48

88 inventors:

goldMedal Venkaiah Chowdary Nannapaneni (26 out of 26 patents)

silverMedal Nannapaneni Venkaiah Chowdary (22 out of 22 patents)

bronzeMedal Bhujanga Rao Adibhatla Kali Satya (16 out of 16 patents)

4.  Durga Prasad Konakanchi (13 out of 14 patents)

5.  Kali Satya Bhujanga Rao Adibhatla (11 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…